Regorafenib improves survival after sorafenib in patients with recurrent HCC after liver transplantation
Titel:
Regorafenib improves survival after sorafenib in patients with recurrent HCC after liver transplantation
Auteur:
Iavarone, M. Invernizzi, F. Ivanics, T. Mazza, S. Zavaglia, C. Sanduzzi-Zamparelli, M. Fraile-López, M. Czauderna, C. Costanzo, G. Di Bhoori, S. Pinter, M. Manini, M.A. Amaddeo, G. Yunquera, A. Fernandez Piñero, F. Rodríguez, M.J. Blanco Anders, M. Soteras, G. Aballay Villadsen, G.E. Yoon, P. Daechul Cesarini, L. Díaz-González, Á. González-Diéguez, M.L. Tortora, R. Weinmann, A. Mazzaferro, V. Cristóbal, M. Romero Crespo, G. Regnault, H. De Giorgio, M. Varela, M. Prince, R. Scuddeler, L. Donato, M.F. Wörns, M.A. Bruix, J. Sapisochin, G. Lampertico, P. Reig, M.